Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Boswellic acid, derived from the resin of the Boswellia serrata tree, has a long history of use in Ayurvedic and traditional medicine for treating inflammatory conditions. More recently, scientific research has explored its anti-inflammatory properties, particularly its ability to inhibit 5-lipoxygenase, an enzyme involved in leukotriene synthesis and inflammatory processes. This mechanism is relevant for respiratory conditions like bronchitis, where inflammation of the bronchial tubes is a key feature.

Some clinical studies and animal research have investigated Boswellia extracts (which contain boswellic acids) for their effects on asthma and chronic obstructive pulmonary disease (COPD), showing modest improvements in symptoms and inflammatory markers. For example, a small randomized controlled trial reported reduced dyspnea and improved lung function in asthma patients using Boswellia extract. However, direct clinical evidence for acute or chronic bronchitis is sparse. Most supporting data are extrapolated from its broader anti-inflammatory effects in the respiratory tract rather than studies specifically targeting bronchitis.

In summary, while there is a scientific rationale based on anti-inflammatory mechanisms and some supporting data from related respiratory conditions, robust clinical evidence for boswellic acid in the treatment or support of bronchitis specifically is limited. Thus, the strength of evidence is moderate to low, primarily supported by mechanistic and preliminary clinical research rather than large, high-quality clinical trials.

More about Boswellic Acid
More about Bronchitis

Other ingredients used for Bronchitis

Other health conditions supported by Boswellic Acid

Products containing Boswellic Acid